In 2004, more than a year before the National Institute of Health (NIH) Clinical and Translational Science Award (CTSA) was announced, Robert J. Alpern, Dean and Ensign Professor of Medicine for the Yale School of Medicine, initiated a strategic planning process to evaluate and further the status of clinical and translational research at the Yale School of Medicine. Two major goals that emerged from the strategic planning process were to expand and centralize the training of the next generation of clinical and translational scientists and to provide a robust infrastructure that would promote innovative and collaborative research directed at improving patient care.
YCCI is the backbone of translational research at Yale. Through mentorship, the promotion of team science, and access to patient volunteers – the heroes of research – we support research that improves health.
View presentations on clinical trial registration and reporting guidelines: